Moreover, tumour necrosis factor (TNF)-α plays a key role in the pathogenesis of RA, and the propensity of anti-TNF-α agents to facilitate infection in patients with RA is a source of concern. The gene discussed is TNF; the disease is rheumatoid arthritis.